Skip to main content
. 2016 Apr 21;30(6):645–659. doi: 10.1210/me.2015-1244

Figure 7. GRK2 and GRK3 are responsible for agonist-induced phosphorylation of the human sst3 receptor.

Figure 7.

A, HEK293 cells stably expressing the sst3 receptor were transfected with siRNA targeted to GRK2, GRK3, GRK5, and GRK6 or nonsilencing siRNA control (SCR) for 72 hours and then exposed to 1μM SS-14 for 10 minutes (room temperature). Cells were lysed and immunoblotted with anti-pS337/pT341 antibodies. Blots were stripped and reprobed with the phosphorylation-independent anti-HA antibody to confirm equal loading of the gels (anti-HA). Receptor monomers were quantified and expressed as percentage of maximal phosphorylation in SCR-transfected cells. Data correspond to the mean ± SEM from 3 independent experiments. Results were analyzed by two-way ANOVA followed by the Bonferroni post hoc test (*, P < .05). The arrow indicates the position of sst3 monomers that were used for quantification. B and C, siRNA knockdown of GRK2, GRK3, GRK5, and GRK6 was confirmed by Western blotting. The positions of molecular mass markers are indicated on the left (in kDa).